Literature DB >> 9243723

Gluten-sensitive enteropathy in Irish setter dogs: characterisation of jejunal microvillar membrane proteins by two-dimensional electrophoresis.

P W Pemberton1, R W Lobley, R Holmes, S H Sørensen, R M Batt.   

Abstract

This study investigated whether gluten-sensitive enteropathy (GSE) in Irish setter dogs was associated with underlying structural abnormalities of microvillar membrane proteins. Jejunal biopsies taken from eight-month-old GSE-affected dogs reared on a normal, gluten-containing diet exhibited partial villous atrophy and contained more intra-epithelial lymphocytes than controls. The morphological abnormalities were reversed by feeding a gluten-free diet for five months and the changes were accompanied by an increase in the mucosal activity of the microvillar hydrolases, particularly aminopeptidase N and dipeptidyl aminopeptidase IV, which reverted to pre-treatment levels after a gluten challenge. Two-dimensional electrophoresis of microvillar membrane proteins isolated from GSE-affected dogs revealed an essentially normal protein map that was comparable to controls. The exception was an intense 85 kDa protein spot that diminished when the affected dogs were fed a gluten-free diet and re-intensified after a gluten challenge.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9243723     DOI: 10.1016/s0034-5288(97)90146-6

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  High antigliadin IgG titers in laboratory rabbits fed a wheat-containing diet: a model for celiac disease?

Authors:  John B March
Journal:  Dig Dis Sci       Date:  2003-03       Impact factor: 3.199

2.  An initial genome-wide investigation of protein-losing enteropathy in Gordon setters: Exploratory observations.

Authors:  Elle K Donnini; Muhammed Walugembe; Max F Rothschild; Albert E Jergens; Karin Allenspach
Journal:  Can J Vet Res       Date:  2021-01       Impact factor: 1.310

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.